Latest Articlesddd
The Medicines Company ORION-10 Study for ASCVD The Medicines Company (MDCO) announced positive topline results from …
Vitiligo Vitiligo is a chronic autoimmune disease. The immune system attacks the pigment-producing melanocyte cells causing …
News from Nektar Nektar Therapeutics (NKTR) announced that new data from patients with metastatic triple-negative breast cancer, …
Prohost Letter #435 The Value of the Biotech Companies A Continuation of Prohost Letter #434 A …
bluebird bio Has Promising Results from Its Lenti-D Gene Therapy for CALD Good results have come …
Atara Biotherapeutics ATA188 for MS Atara Biotherapeutics (ATRA) announced the presentation of initial efficacy data as …
Migraine's Really Effective Treatments The years 2018 and 2019 could be called the years of migraine’s …
Moderna Therapeutics Trial Results Moderna Therapeutics (MRNA) trial results mark the first systemic mRNA therapeutic to …
Diseases of the Back of the Eye
Diseases of the back of the eye, such as: age-related …
Amgen's Outperforming After being boxed in, for the past couple of weeks, Amgen’s (AMGN) stock finally outperformed. …
Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …
Outperforming Biotechs On August 27, 2019 we posted “The Medicines Company Has Agreeable News” under Today’s …
Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …
The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …
Amgen Agreement with Celgene for Otezla® In the News Amgen (AMGN) entered into an agreement with …
AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca (AZN) has good news. Many of them …
From Moderna From the press release we learned that the U.S. Food and Drug Administration (FDA) …
The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …
Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved …
Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
